Related Experiment Video
Updated: Aug 14, 2026
Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy
A M Mhashilkar1, R D Schrock, M Hindi
1Introgen Therapeutics Inc, Houston, TX 77030, USA.
Background:
The mda-7 gene (melanoma differentiation associated gene-7) is a novel tumor suppressor gene. The anti-proliferative activity of MDA-7 has been previously reported. In this report, we analyze the anti-tumor efficacy of Ad-mda7 in a broad spectrum of cancer lines.
Materials And Methods:
Ad-mda7-transduced cancer or normal cell lines were assayed for cell proliferation (tritiated thymidine incorporation assay, Alamar blue assay, and trypan-blue exclusion assay), apoptosis (TUNEL, and Annexin V staining visualized by fluorescent microscopy or FACs analysis), and cell cycle regulation (Propidium Iodide staining and FACs analysis).
Results:
Ad-mda7 treatment of tumor cells resulted in growth inhibition and apoptosis in a temporal and dose-dependent manner. The anti-tumor effects were independent of the genomic status of p53, RB, p16, ras, bax, and caspase 3 in these cells. In addition, normal cell lines did not show inhibition of proliferation or apoptotic response to Ad-mda7. Moreover, Ad-mda7-transduced cancer cells secreted a soluble form of MDA-7 protein. Thus, Ad-mda7 may represent a novel gene-therapeutic agent for the treatment of a variety of cancers.
Conclusions:
The potent and selective killing activity of Ad-mda7 in cancer cells but not in normal cells makes this vector a potential candidate for cancer gene therapy.
Insights
Ad-mda7 effectively inhibits cancer cell growth and induces apoptosis, regardless of specific gene mutations. This novel gene therapy shows selective anti-tumor activity, sparing normal cells, making it a promising candidate for cancer treatment.
Area of Science:
- Oncology
- Gene Therapy
- Molecular Biology
Background:
- The mda-7 gene (melanoma differentiation associated gene-7) functions as a tumor suppressor.
- Previous studies indicated MDA-7 possesses anti-proliferative properties.
- This research investigates the anti-tumor potential of Ad-mda7 across diverse cancer cell lines.
Purpose of the Study:
- To evaluate the anti-tumor efficacy of Ad-mda7.
- To determine the selectivity of Ad-mda7's anti-cancer effects on normal versus tumor cells.
- To assess the impact of Ad-mda7 on cancer cell proliferation, apoptosis, and cell cycle.
Main Methods:
- Cell proliferation was measured using tritiated thymidine incorporation, Alamar blue, and trypan-blue exclusion assays.
- Apoptosis was assessed via TUNEL and Annexin V staining, visualized by microscopy or flow cytometry (FACs).
- Cell cycle regulation was analyzed using Propidium Iodide staining and FACs analysis.
Main Results:
- Ad-mda7 treatment led to dose- and time-dependent growth inhibition and apoptosis in tumor cells.
- These anti-tumor effects were observed irrespective of the p53, RB, p16, ras, bax, and caspase 3 genomic status.
- Normal cell lines exhibited no significant inhibition of proliferation or apoptotic response to Ad-mda7.
- Ad-mda7-transduced cancer cells secreted a soluble MDA-7 protein.
Conclusions:
- Ad-mda7 demonstrates potent and selective anti-cancer activity.
- Its ability to target cancer cells while sparing normal cells positions it as a viable candidate for cancer gene therapy.
Related Concept Videos
02:23Abnormal Proliferation
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...